Showing results (961-970 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|March 21, 2000
Acamprosate. Pharmacoeconomic implications of therapyR H Foster, K J McClellanPharmacoeconomics|October 28, 1999
Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimensJ UrquhartPharmacoeconomics|October 28, 1999
New drugs for osteoporosis. Comparison of the costs and required returns with those of other drugs intended for long-term useM EdwardsPharmacoeconomics|October 28, 1999
Pharmaceutical price regulation. A study on the impact of the rate-of-return regulation in the UKJ R BorrellPharmacoeconomics|October 28, 1999
A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspectiveL Lacey, M Youle, P Trueman, et al.Pharmacoeconomics|October 28, 1999
The clinical and economic potential of cyclosporin drug interactionsJ E Martin, A J Daoud, T J Schroeder, et al.Pharmacoeconomics|October 28, 1999
Utility scores for chronic conditions in a community-dwelling populationN Mittmann, K Trakas, N Risebrough, et al.Pharmacoeconomics|October 28, 1999
Prescribing at the interface between primary and secondary care in the UK. Towards joint formularies?M Duerden, T WalleyPharmacoeconomics|October 28, 1999
Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trialS H Hamilton, D A Revicki, E T Edgell, et al.Pharmacoeconomics|February 8, 2000
Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis. A reviewM B Nichol, A S HaradaPageof 336